OBJECTIVE: To assess migration of CD34(+) human stem cells to the bone marrow of athymic mice by using magnetic resonance (MR) imaging and Resovist, a contrast agent containing superparamagnetic iron oxide (SPIO) particles. METHODS: All animal and human procedures were approved by our institution's ethics committee, and women had given consent to donate umbilical cord blood (UCB). Balb/c-AnN Foxn1(nu)/Crl mice received intravenous injection of 1 x 10(6) (n=3), 5 x 10(6) (n=3) or 1 x 10(7) (n=3) human Resovist-labelled CD34(+) cells; control mice received Resovist (n=3). MR imaging was performed before, 2 and 24 h after transplantation. Signal intensities of liver, muscle and bone marrow were measured and analysed by ANOVA and post hoc Student's t tests. MR imaging data were verified by histological and immunological detection of both human cell surface markers and carboxydextrancoating of the contrast agent. RESULTS: CD34(+) cells were efficiently labelled by Resovist without impairment of functionality. Twenty-four hours after administration of labelled cells, MR imaging revealed a significant signal decline in the bone marrow, and histological and immunological analyses confirmed the presence of transplanted human CD34(+) cells. CONCLUSION: Intravenously administered Resovist-labelled CD34(+) cells home to bone marrow of mice. Homing can be tracked in vivo by using clinical 1.5-T MR imaging technology.
OBJECTIVE: To assess migration of CD34(+) human stem cells to the bone marrow of athymic mice by using magnetic resonance (MR) imaging and Resovist, a contrast agent containing superparamagnetic iron oxide (SPIO) particles. METHODS: All animal and human procedures were approved by our institution's ethics committee, and women had given consent to donate umbilical cord blood (UCB). Balb/c-AnN Foxn1(nu)/Crl mice received intravenous injection of 1 x 10(6) (n=3), 5 x 10(6) (n=3) or 1 x 10(7) (n=3) human Resovist-labelled CD34(+) cells; control mice received Resovist (n=3). MR imaging was performed before, 2 and 24 h after transplantation. Signal intensities of liver, muscle and bone marrow were measured and analysed by ANOVA and post hoc Student's t tests. MR imaging data were verified by histological and immunological detection of both human cell surface markers and carboxydextrancoating of the contrast agent. RESULTS:CD34(+) cells were efficiently labelled by Resovist without impairment of functionality. Twenty-four hours after administration of labelled cells, MR imaging revealed a significant signal decline in the bone marrow, and histological and immunological analyses confirmed the presence of transplanted humanCD34(+) cells. CONCLUSION: Intravenously administered Resovist-labelled CD34(+) cells home to bone marrow of mice. Homing can be tracked in vivo by using clinical 1.5-T MR imaging technology.
Authors: Motonari Kondo; Amy J Wagers; Markus G Manz; Susan S Prohaska; David C Scherer; Georg F Beilhack; Judith A Shizuru; Irving L Weissman Journal: Annu Rev Immunol Date: 2002-12-17 Impact factor: 28.527
Authors: Forhad Ahmed; Stuart J Ings; Arnold R Pizzey; Michael P Blundell; Adrian J Thrasher; Hong T Ye; Anne Fahey; David C Linch; Kwee L Yong Journal: Blood Date: 2003-11-20 Impact factor: 22.113
Authors: Heike E Daldrup-Link; Martina Rudelius; Guido Piontek; Stephan Metz; Rosalinde Bräuer; Gerlinde Debus; Claire Corot; Jürgen Schlegel; Thomas M Link; Christian Peschel; Ernst J Rummeny; Robert A J Oostendorp Journal: Radiology Date: 2005-01 Impact factor: 11.105
Authors: Ali S Arbab; Gene T Yocum; Heather Kalish; Elaine K Jordan; Stasia A Anderson; Aarif Y Khakoo; Elizabeth J Read; Joseph A Frank Journal: Blood Date: 2004-04-20 Impact factor: 22.113
Authors: Mary Eapen; Pablo Rubinstein; Mei-Jie Zhang; Cladd Stevens; Joanne Kurtzberg; Andromachi Scaradavou; Fausto R Loberiza; Richard E Champlin; John P Klein; Mary M Horowitz; John E Wagner Journal: Lancet Date: 2007-06-09 Impact factor: 79.321
Authors: Joseph A Frank; Brad R Miller; Ali S Arbab; Holly A Zywicke; E Kay Jordan; Bobbi K Lewis; L Henry Bryant; Jeff W M Bulte Journal: Radiology Date: 2003-06-20 Impact factor: 11.105
Authors: Fahd Azzabi; Markus Rottmar; Virginija Jovaisaite; Markus Rudin; Tullio Sulser; Andreas Boss; Daniel Eberli Journal: Tissue Eng Part C Methods Date: 2014-08-04 Impact factor: 3.056